Konyang University Hospital has partnered with Japan's National Institutes for Quantum Science and Technology (QST) to study ...

Neurophet, a Korean brain imaging software firm, is making a high-stakes bet on Alzheimer’s, and it’s counting on Eli Lilly ...

Four risk factors increase the risk of developing stomach cancer, one of the most common cancers in Korea. These are ...

Rhythm Pharmaceuticals, a U.S. company that bought a global license from LG Chem for its oral orphan obesity drug Bivamelagon ...

Yuhan Corp. is exploring various collaborative strategies to develop new obesity drugs. In addition to securing the ...

Astellas Korea will reapply for health insurance coverage for its new drug Vyloy (zolbetuximab), a targeted treatment for ...

A medical society has recommended expanding national mandatory vaccinations for major infectious diseases that threaten the ...

Huons Group held a ceremony Friday at its headquarters in Pangyo, Seongnam, Gyeonggi Province, to commemorate the company’s ...

Korea's Lotte Biologics is stacking up its antibody-drug conjugate (ADC) partnerships, this time tapping AbTis, Dong-A ST’s ...

Yuhan Corp. is wrapping up its chemo-free phase 2 lung cancer trial just as Johnson & Johnson pushes for reimbursement of ...

Citrelin (taltirelin), a treatment for spinocerebellar degeneration (SCD), a neurological disease, has crossed the threshold ...

The world feels more unpredictable than ever. Economies around the globe are reeling from new U.S. tariff policies, military ...